437 related articles for article (PubMed ID: 27305909)
1. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
3. ING1 and ING2: multifaceted tumor suppressor genes.
Guérillon C; Larrieu D; Pedeux R
Cell Mol Life Sci; 2013 Oct; 70(20):3753-72. PubMed ID: 23412501
[TBL] [Abstract][Full Text] [Related]
4. Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors.
Bartsch S; Mirzakhani K; Neubert L; Stenzel A; Ehsani M; Esmaeili M; Pungsrinont T; Kacal M; Rasa SMM; Kallenbach J; Damodaran D; Ribaudo F; Grimm MO; Neri F; Baniahmad A
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439179
[TBL] [Abstract][Full Text] [Related]
5. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
6. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
[TBL] [Abstract][Full Text] [Related]
7. ING2 controls the G1 to S-phase transition by regulating p21 expression.
Larrieu D; Ythier D; Brambilla C; Pedeux R
Cell Cycle; 2010 Oct; 9(19):3984-90. PubMed ID: 20890119
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor p33ING1b upregulates p16INK4a expression and induces cellular senescence.
Li N; Li Q; Cao X; Zhao G; Xue L; Tong T
FEBS Lett; 2011 Oct; 585(19):3106-12. PubMed ID: 21896275
[TBL] [Abstract][Full Text] [Related]
9. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
[TBL] [Abstract][Full Text] [Related]
10. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer.
Lim SC; Geleta B; Maleki S; Richardson DR; Kovačević Ž
J Biol Chem; 2021 Dec; 297(6):101414. PubMed ID: 34785213
[TBL] [Abstract][Full Text] [Related]
11. ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer.
Melekhova A; Baniahmad A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685579
[TBL] [Abstract][Full Text] [Related]
12. ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells.
Sarker KP; Kataoka H; Chan A; Netherton SJ; Pot I; Huynh MA; Feng X; Bonni A; Riabowol K; Bonni S
J Biol Chem; 2008 May; 283(19):13269-79. PubMed ID: 18334480
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
14. The ING tumor suppressors in cellular senescence and chromatin.
Ludwig S; Klitzsch A; Baniahmad A
Cell Biosci; 2011 Jul; 1(1):25. PubMed ID: 21767350
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic, full length and novel cleaved variant, TBLR1 reduces apoptosis in prostate cancer under androgen deprivation.
Daniels G; Zhang X; Zhong X; Santiago L; Wang LH; Wu X; Zhang JY; Liang F; Li X; Neubert TA; Steinke L; Shen Y; Basch R; Schneider R; Levy DE; Lee P
Oncotarget; 2016 Jun; 7(26):39556-39571. PubMed ID: 27127173
[TBL] [Abstract][Full Text] [Related]
16. The activation of OR51E1 causes growth suppression of human prostate cancer cells.
Maßberg D; Jovancevic N; Offermann A; Simon A; Baniahmad A; Perner S; Pungsrinont T; Luko K; Philippou S; Ubrig B; Heiland M; Weber L; Altmüller J; Becker C; Gisselmann G; Gelis L; Hatt H
Oncotarget; 2016 Jul; 7(30):48231-48249. PubMed ID: 27374083
[TBL] [Abstract][Full Text] [Related]
17. Nuclear ING2 expression is reduced in osteosarcoma.
Han XR; Bai XZ; Sun Y; Yang Y
Oncol Rep; 2014 Nov; 32(5):1967-72. PubMed ID: 25190103
[TBL] [Abstract][Full Text] [Related]
18. ING3 promotes prostate cancer growth by activating the androgen receptor.
Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT
BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel androgen receptor target genes in prostate cancer.
Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
[TBL] [Abstract][Full Text] [Related]
20. Ing1 mediates p53 accumulation and chromatin modification in response to oncogenic stress.
Abad M; Menéndez C; Füchtbauer A; Serrano M; Füchtbauer EM; Palmero I
J Biol Chem; 2007 Oct; 282(42):31060-7. PubMed ID: 17693408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]